Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors

M. G. Ward*, B. Warner, N. Unsworth, S. W. Chuah, C. Brownclarke, S. Shieh, M. Parkes, J. D. Sanderson, Z. Arkir, J. Reynolds, P. R. Gibson, P. M. Irving

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

62 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors'. Together they form a unique fingerprint.